Secondary Logo

Journal Logo

Articles by Florian Lemaitre, PharmD

Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology

Bergan, Stein; Brunet, Mercè; Hesselink, Dennis A.; More

Therapeutic Drug Monitoring. 43(2):150-200, April 2021.

Measuring Intracellular Concentrations of Calcineurin Inhibitors: Expert Consensus from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Expert Panel

Lemaitre, Florian; Vethe, Nils T.; D'Avolio, Antonio; More

Therapeutic Drug Monitoring. 42(5):665-670, October 2020.

Redefining Therapeutic Drug Monitoring of Tacrolimus in Patients Undergoing Liver Transplantation: A Target Trough Concentration of 4–7 ng/mL During the First Month After Liver Transplantation is Safe and Improves Graft and Renal Function

Lemaitre, Florian; Tron, Camille; Renard, Thomas; More

Therapeutic Drug Monitoring. 42(5):671-678, October 2020.

Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report

Brunet, Mercè; van Gelder, Teun; Åsberg, Anders; More

Therapeutic Drug Monitoring. 41(3):261-307, June 2019.

Ex Vivo Model to Decipher the Impact of Extracorporeal Membrane Oxygenation on Beta-lactam Degradation Kinetics

Leven, Cyril; Fillâtre, Pierre; Petitcollin, Antoine; More

Therapeutic Drug Monitoring. 39(2):180-184, April 2017.

Impact of Extracorporeal Membrane Oxygenation and Continuous Venovenous Hemodiafiltration on the Pharmacokinetics of Oseltamivir Carboxylate in Critically Ill Patients With Pandemic (H1N1) Influenza

Lemaitre, Florian; Luyt, Charles-Edouard; Roullet-Renoleau, François; More

Therapeutic Drug Monitoring. 34(2):171-175, April 2012.